| Symbol | Company | Weighting |
|---|---|---|
| ABVX | ABIVAX SA | 15.95% |
| GH | GUARDANT HEALTH INC | 4.73% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 4.69% |
| AMLX | AMYLYX PHARMACEUTICALS INC | 3.47% |
| INSM | INSMED INC | 2.72% |
| AXSM | AXSOME THERAPEUTICS INC. | 2.49% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 2.30% |
| TVTX | TRAVERE THERAPEUTICS INC | 2.21% |
| RVMD | REVOLUTION MEDICINES INC | 2.17% |
| NAMS | NEWAMSTERDAM PHARMA CO NV | 1.98% |
| PEN | PENUMBRA INC | 1.96% |
| HCA | HCA HOLDINGS INC | 1.85% |
| AZN | ASTRAZENECA PLC-ADR | 1.84% |
| ARGX | ARGENX SE ADR | 1.76% |
| MCK | MCKESSON CORP | 1.74% |
| LLY | ELI LILLY CORP | 1.74% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.62% |
| CYTK | CYTOKINETICS INC | 1.60% |
| THC | TENET HEALTHCARE CORP | 1.60% |
| IDYA | IDEAYA BIOSCIENCES, INC | 1.59% |
| IMTX | IMMATICS NV | 1.56% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.46% |
| MRK | MERCK & CO. NEW | 1.44% |
| BIIB | BIOGEN INC | 1.44% |
| NUVL | NUVALENT INC | 1.43% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.38% |
| RMD | RESMED INC | 1.31% |
| BSX | BOSTON SCIENTIFIC | 1.30% |
| ISRG | INTUITIVE SURGICAL INC | 1.27% |
| IMVT | IMMUNOVANT INC | 1.27% |
| SNY | SANOFI- AVENTIS- ADR | 1.25% |
| SYK | STRYKER CORP | 1.25% |
| REGN | REGENERON PHARMACEUTICALS | 1.24% |
| DXCM | DEXCOM INC | 1.24% |
| ABT | ABBOTT LABORATORIES | 1.20% |
| ALC | ALCON INC | 1.20% |
| ELV | ELEVANCE HEALTH INC | 1.17% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.17% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.15% |
| ICLR | ICON PLC | 1.14% |
| EWTX | EDGEWISE THERAPEUTICS | 1.12% |
| BDX | BECTON DICKINSON & CO | 1.12% |
| GKOS | GLAUKOS CORPORATION | 1.06% |
| CI | THE CIGNA GROUP | 1.04% |
| COO | COOPER COS INC | 1.03% |
| SMMT | SUMMIT THERAPEUTICS INC. | 0.99% |
| ZTS | ZOETIS INC | 0.90% |
| TNDM | TANDEM DIABETES CARE INC | 0.84% |
| HUM | HUMANA INC | 0.82% |
| PCVX | VAXCYTE INC | 0.79% |
| MOH | MOLINA HEALTHCARE INC | 0.76% |
| ARVN | ARVINAS INC USD | 0.75% |
| NVO | NOVO NORDISK A/S | 0.70% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 0.66% |
| UNH | UNITEDHEALTH GROUP INC | 0.61% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 0.51% |
| GERN | GERON CORP | 0.44% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.